SEARCH RESULT

Total Matching Records found : 59

Not consulted on scrapping drug pricing agency: Chairman -Vidya Krishnan

-The Hindu New Delhi: Days after it was revealed that the Centre is likely to dismantle the National Pharmaceutical Pricing Agency (NPPA), its chairman said the decision was ‘rushed’ and the agency was not consulted. “There were two meetings and the NPPA was not a party to them. Both meetings were held at short notice. This has been a rushed decision. For any policy change, there needs to be consultation. I understand...

More »

A disaster in the making -A Rangarajan

-Frontline Medecins Sans Frontieres warns that the free or regional trade agreements that are being negotiated, which seek to strengthen current patent regimes, are a potential threat to the developing world’s access to life-saving drugs, which it sources mostly from India. WHEN NELSON MANDELA’S GOVERNMENT passed the Medicines and Related Substances Control Act in 1997 to make medicines more accessible to the poor, 39 big pharmaceutical companies filed law suits in...

More »

Hepatitis C cure may cost as low as Rs 67k -Reema Nagarajan

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...

More »

Nudge to tweak TB treatment rules -GS Mudur

-The Telegraph New Delhi: India could prevent on average 18,000 people from developing multi-drug-resistant tuberculosis every year over the next decade if the health ministry accelerates proposed changes in TB diagnosis and treatment policies, public health experts have said. A study by the health ministry's TB division has estimated that India could avert 180,000 cases of MDR-TB between 2015 and 2025 if most patients who seek government treatment are tested for MDR-TB...

More »

Sunita Narain, director general, Centre for Science and Environment, interviewed by Ajoy Ashirwad Mahaprashasta & Venkitesh Ramakrishnan

THE controversy over Maggi instant noodles has once again highlighted the issues plaguing food safety in India. Not only does the issue raise critical questions about safe food production by multinational companies such as Nestle but it also foregrounds the institutional fault lines when it comes to ensuring food safety. Frontline spoke to Sunita Narain, who heads the New Delhi-based Centre for Science and Environment (CSE), the organisation instrumental in initiating...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close